339 related articles for article (PubMed ID: 4283271)
21. Studies on immunity to autochthonous mouse tumors.
Hellström I; Hellström KE; Pierce GE; Fefer A
Transplant Proc; 1969 Mar; 1(1):90-4. PubMed ID: 5406848
[No Abstract] [Full Text] [Related]
22. Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV)-induced tumors and transplanted lymphomas.
Leclerc JC; Gomard E; Levy JP
Int J Cancer; 1972 Nov; 10(3):589-601. PubMed ID: 4128690
[No Abstract] [Full Text] [Related]
23. Tumor-associated membrane antigens and the antitumor immune reactions.
Levy JP; Kourilsky FM
Transplant Proc; 1973 Dec; 5(4):1435-40. PubMed ID: 4130056
[No Abstract] [Full Text] [Related]
24. Immunologic and virologic studies of a nonproducer tumor induced by murine sarcoma virus (Harvey).
McCoy JL; Ting RC; Morton DL; Law LW
J Natl Cancer Inst; 1972 Feb; 48(2):383-91. PubMed ID: 4347035
[No Abstract] [Full Text] [Related]
25. Biological significance of histocompatibility antigens.
Fed Proc; 1972; 31(3):1087-104. PubMed ID: 4113383
[No Abstract] [Full Text] [Related]
26. [The modelling of the growth of Ehrlich carcinoma and teratoma T-36 with ascitic fluid and tumor-cell dialysate].
Donenko FV; Kabieva AO; Moroz LV
Biull Eksp Biol Med; 1992 Jul; 114(8):193-5. PubMed ID: 1467492
[TBL] [Abstract][Full Text] [Related]
27. [Extended survival of allographs in mice following the injection of transplantation antigens pre-treated with normal serum. II. Mode of action (author's transl)].
Elie R; Lamoureux G
Ann Immunol (Paris); 1974 Jun; 125 C(4):645-53. PubMed ID: 4615620
[No Abstract] [Full Text] [Related]
28. [Effect of the nucleic acids from the ascitic fluid of Ehrlich's tumor on its transplantability].
Belokhvostov AS; Grikurova NK
Vopr Onkol; 1981; 27(12):56-9. PubMed ID: 7324403
[TBL] [Abstract][Full Text] [Related]
29. Heterogenization of normal tissues in oncogenesis. A skeptical review.
Mariani T; Good RA
Isr J Med Sci; 1973 Mar; 9(3):380-94. PubMed ID: 4575655
[No Abstract] [Full Text] [Related]
30. Effect of cortisone on oncogenesis by murine sarcoma virus (Moloney).
Shachat DA; Fefer A; Moloney JB
Cancer Res; 1968 Mar; 28(3):517-20. PubMed ID: 4867925
[No Abstract] [Full Text] [Related]
31. [The effect of ascitic fluid on the growth of Ehrlich tumor and Lewis carcinoma].
Donenko FV; Kabieva AO; Moroz LV
Biull Eksp Biol Med; 1992 Jul; 114(8):191-3. PubMed ID: 1467491
[TBL] [Abstract][Full Text] [Related]
32. Studies on the growth and regression of a transplantable Moloney sarcoma.
Fefer A; McCoy JL; Glynn JP
Cancer Res; 1967 Nov; 27(11):2207-11. PubMed ID: 4864248
[No Abstract] [Full Text] [Related]
33. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
Olinescu A; Hristescu S; Mazilu E
Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of murine C-type viruses. 3. Antigenic conversion and focus induction.
Grundner G; Fenyö EM; Klein E
Int J Cancer; 1974 Mar; 13(3):412-9. PubMed ID: 4362613
[No Abstract] [Full Text] [Related]
35. Central problems in tumor immunology, 1976.
Weiss DW
Isr J Med Sci; 1976; 12(4-5):281-7. PubMed ID: 1084878
[No Abstract] [Full Text] [Related]
36. Tumor-induced skin heterogenization. 3. Immunologic and immunogenetic mechanisms.
Liozner AL; Svet-Moldavsky GJ; Mkheidze DM
J Natl Cancer Inst; 1970 Sep; 45(3):485-94. PubMed ID: 4943065
[No Abstract] [Full Text] [Related]
37. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
Vallera DA; Mentzer SJ; Maizel SE
Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
[TBL] [Abstract][Full Text] [Related]
38. In vitro cytotoxicity of normal serum factor(s) on neuraminidase-treated Ehrlich ascites tumor cells and murine leukemia L 1210 cells.
Sethi KK; Brandis H
Z Immunitatsforsch Exp Klin Immunol; 1972 May; 143(4):426-9. PubMed ID: 4282925
[No Abstract] [Full Text] [Related]
39. [Nonspecific suppressive effect of Ehrlich tumor ascitic fluid on transplantation immunity].
Belokhvostov AS; Zelenkova NK
Biull Eksp Biol Med; 1978 Oct; 86(10):474-6. PubMed ID: 361103
[TBL] [Abstract][Full Text] [Related]
40. Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.
Weissman IL
J Natl Cancer Inst; 1973 Aug; 51(2):443-8. PubMed ID: 4765368
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
